FRESENIUS MEDICAL CARE AG Comprehensive Income Attributable To Noncontrolling Interests
FRESENIUS MEDICAL CARE AG (FMCQF) reported Comprehensive Income Attributable To Noncontrolling Interests of EUR 81.59 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-24.
Financial Statements › Income Statement › Unrealized Gains
ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests · last filed 2026-02-24
- FRESENIUS MEDICAL CARE AG comprehensive income attributable to noncontrolling interests for the quarter ending 2025-12-31 was 73.27M EUR, a 45.59% decline year-over-year.
- FRESENIUS MEDICAL CARE AG comprehensive income attributable to noncontrolling interests for the quarter ending 2025-09-30 was 49.73M EUR, a 9767.06% increase year-over-year.
- FRESENIUS MEDICAL CARE AG comprehensive income attributable to noncontrolling interests for the quarter ending 2025-06-30 was -36.55M EUR, a 156.79% decline year-over-year.
- FRESENIUS MEDICAL CARE AG comprehensive income attributable to noncontrolling interests for the quarter ending 2025-03-31 was -4.86M EUR, a 106.68% decline year-over-year.
| Period end | Comprehensive Income Attributable To Noncontrolling Interests 3 month | Comprehensive Income Attributable To Noncontrolling Interests 3 month as first filed | Comprehensive Income Attributable To Noncontrolling Interests 6 month | Comprehensive Income Attributable To Noncontrolling Interests 6 month as first filed | Comprehensive Income Attributable To Noncontrolling Interests 9 month | Comprehensive Income Attributable To Noncontrolling Interests 9 month as first filed | Comprehensive Income Attributable To Noncontrolling Interests 12 month |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | 73.27M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-24 | 123.00M EUR derived: sum of 2 quarters · filed 2026-02-24 | 86.45M EUR derived: sum of 3 quarters · filed 2026-02-24 | 81.59M EUR 20-F · filed 2026-02-24 | |||
| 2025-09-30 | 49.73M EUR 6-K · filed 2025-11-04 | 13.18M EUR derived: sum of 2 quarters · filed 2025-11-04 | 8.32M EUR 6-K · filed 2025-11-04 | 142.98M EUR derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2025-06-30 | -36.55M EUR 6-K · filed 2025-08-05 | -41.41M EUR 6-K · filed 2025-08-05 | 93.25M EUR derived: sum of 3 quarters · filed 2026-02-24 | 93.75M EUR derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2025-03-31 | -4.86M EUR 6-K · filed 2025-05-06 | 129.80M EUR derived: sum of 2 quarters · filed 2026-02-24 | 130.31M EUR derived: sum of 3 quarters · filed 2026-02-24 | 194.67M EUR derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2024-12-31 | 134.66M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-24 | 135.16M EUR derived: sum of 2 quarters · filed 2026-02-24 | 199.53M EUR derived: sum of 3 quarters · filed 2026-02-24 | 272.24M EUR 20-F · filed 2026-02-24 | |||
| 2024-09-30 | 504.00K EUR 6-K · filed 2025-11-04 | 64.87M EUR derived: sum of 2 quarters · filed 2025-11-04 | 137.57M EUR 6-K · filed 2025-11-04 | 155.15M EUR derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2024-06-30 | 64.36M EUR 6-K · filed 2025-08-05 | 137.07M EUR 6-K · filed 2025-08-05 | 154.65M EUR derived: sum of 3 quarters · filed 2026-02-24 | 250.31M EUR derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2024-03-31 | 72.71M EUR 6-K · filed 2025-05-06 | 90.28M EUR derived: sum of 2 quarters · filed 2026-02-24 | 185.95M EUR derived: sum of 3 quarters · filed 2026-02-24 | 241.28M EUR derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2023-12-31 | 17.58M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-24 | 113.25M EUR derived: sum of 2 quarters · filed 2026-02-24 | 168.57M EUR derived: sum of 3 quarters · filed 2026-02-24 | 190.02M EUR 20-F · filed 2026-02-24 | |||
| 2023-09-30 | 95.67M EUR 6-K · filed 2024-11-05 | 150.99M EUR derived: sum of 2 quarters · filed 2024-11-05 | 172.44M EUR 6-K · filed 2024-11-05 | 90.30M EUR derived: sum of 4 quarters · filed 2025-02-25 | |||
| 2023-06-30 | 55.32M EUR 6-K · filed 2024-07-30 | 76.78M EUR 6-K · filed 2024-07-30 | -5.37M EUR derived: sum of 3 quarters · filed 2025-02-25 | 135.78M EUR derived: sum of 4 quarters · filed 2025-02-25 | |||
| 2023-03-31 | 21.45M EUR 6-K · filed 2024-05-07 | -60.69M EUR derived: sum of 2 quarters · filed 2025-02-25 | 80.46M EUR derived: sum of 3 quarters · filed 2025-02-25 | 222.21M EUR derived: sum of 4 quarters · filed 2025-02-25 | |||
| 2022-12-31 | -82.15M EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-02-25 | 59.00M EUR derived: sum of 2 quarters · filed 2025-02-25 | 200.75M EUR derived: sum of 3 quarters · filed 2025-02-25 | 280.22M EUR 20-F · filed 2025-02-25 | |||
| 2022-09-30 | 141.15M EUR 6-K · filed 2023-11-02 | 282.90M EUR derived: sum of 2 quarters · filed 2023-11-02 | 362.37M EUR 6-K · filed 2023-11-02 | 464.33M EUR derived: sum of 4 quarters · filed 2024-02-20 | |||
| 2022-06-30 | 141.75M EUR 6-K · filed 2023-08-02 | 221.22M EUR 6-K · filed 2023-08-02 | 323.18M EUR derived: sum of 3 quarters · filed 2024-02-20 | 409.79M EUR derived: sum of 4 quarters · filed 2024-02-20 | |||
| 2022-03-31 | 79.47M EUR 6-K · filed 2022-05-04 | 181.43M EUR derived: sum of 2 quarters · filed 2024-02-20 | 268.04M EUR derived: sum of 3 quarters · filed 2024-02-20 | 315.07M EUR derived: sum of 4 quarters · filed 2024-02-20 | |||
| 2021-12-31 | 101.96M EUR derived: 20-F 12 month − 6-K 9 month · filed 2024-02-20 | 188.57M EUR derived: sum of 2 quarters · filed 2024-02-20 | 235.60M EUR derived: sum of 3 quarters · filed 2024-02-20 | 339.58M EUR 20-F · filed 2024-02-20 | |||
| 2021-09-30 | 86.61M EUR 6-K · filed 2022-10-31 | 133.64M EUR derived: sum of 2 quarters · filed 2022-10-31 | 237.62M EUR 6-K · filed 2022-10-31 | 250.29M EUR derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-06-30 | 47.03M EUR 6-K · filed 2022-08-02 | 151.01M EUR 6-K · filed 2022-08-02 | 163.68M EUR derived: sum of 3 quarters · filed 2023-02-22 | 178.20M EUR derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-03-31 | 103.98M EUR 6-K · filed 2022-05-04 | 116.65M EUR derived: sum of 2 quarters · filed 2023-02-22 | 131.17M EUR derived: sum of 3 quarters · filed 2023-02-22 | 185.70M EUR derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2020-12-31 | 12.67M EUR derived: 20-F 12 month − 6-K 9 month · filed 2023-02-22 | 27.19M EUR derived: sum of 2 quarters · filed 2023-02-22 | 81.72M EUR derived: sum of 3 quarters · filed 2023-02-22 | 171.81M EUR 20-F · filed 2023-02-22 | |||
| 2020-09-30 | 14.53M EUR 6-K · filed 2021-11-02 | 69.05M EUR derived: sum of 2 quarters · filed 2021-11-02 | 159.14M EUR 6-K · filed 2021-11-02 | 186.92M EUR derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2020-06-30 | 54.52M EUR 6-K · filed 2021-07-30 | 144.62M EUR 6-K · filed 2021-07-30 | 172.40M EUR derived: sum of 3 quarters · filed 2022-02-22 | 280.23M EUR derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2020-03-31 | 90.09M EUR 6-K · filed 2021-05-06 | 117.87M EUR derived: sum of 2 quarters · filed 2022-02-22 | 225.70M EUR derived: sum of 3 quarters · filed 2022-02-22 | 271.26M EUR derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2019-12-31 | 27.78M EUR derived: 20-F 12 month − 6-K 9 month · filed 2022-02-22 | 135.61M EUR derived: sum of 2 quarters · filed 2022-02-22 | 181.16M EUR derived: sum of 3 quarters · filed 2022-02-22 | 259.18M EUR 20-F · filed 2022-02-22 | |||
| 2019-09-30 | 107.83M EUR 6-K · filed 2020-10-29 | 107.85M EUR 6-K · filed 2019-10-31 | 153.38M EUR derived: sum of 2 quarters · filed 2020-10-29 | 231.40M EUR 6-K · filed 2020-10-29 | 308.67M EUR derived: sum of 4 quarters · filed 2021-02-23 | ||
| 2019-06-30 | 45.55M EUR 6-K · filed 2020-07-30 | -45.55M EUR 6-K · filed 2019-07-30 | 123.57M EUR 6-K · filed 2020-07-30 | 123.56M EUR 6-K · filed 2019-07-30 | 200.84M EUR derived: sum of 3 quarters · filed 2021-02-23 | 270.53M EUR derived: sum of 4 quarters · filed 2021-02-23 | |
| 2019-03-31 | 78.02M EUR 6-K · filed 2020-05-06 | -78.00M EUR 6-K · filed 2019-05-02 | 155.28M EUR derived: sum of 2 quarters · filed 2021-02-23 | 224.98M EUR derived: sum of 3 quarters · filed 2021-02-23 | 337.94M EUR derived: sum of 4 quarters · filed 2021-02-23 | ||
| 2018-12-31 | 77.26M EUR derived: 20-F 12 month − 6-K 9 month · filed 2021-02-23 | 146.96M EUR derived: sum of 2 quarters · filed 2021-02-23 | 259.92M EUR derived: sum of 3 quarters · filed 2021-02-23 | 285.69M EUR 20-F · filed 2021-02-23 | |||
| 2018-09-30 | 69.69M EUR 6-K · filed 2019-10-31 | -69.69M EUR 6-K · filed 2018-10-30 | 182.65M EUR derived: sum of 2 quarters · filed 2019-10-31 | 208.43M EUR 6-K · filed 2019-10-31 | -208.43M EUR 6-K · filed 2018-10-30 | 449.73M EUR derived: sum of 4 quarters · filed 2020-02-20 | |
| 2018-06-30 | 112.96M EUR 6-K · filed 2019-07-30 | -112.96M EUR 6-K · filed 2018-08-01 | 138.73M EUR 6-K · filed 2019-07-30 | -138.73M EUR 6-K · filed 2018-08-01 | 380.04M EUR derived: sum of 3 quarters · filed 2020-02-20 | 410.23M EUR derived: sum of 4 quarters · filed 2020-02-20 | |
| 2018-03-31 | 25.78M EUR 6-K · filed 2019-05-02 | 267.08M EUR derived: sum of 2 quarters · filed 2020-02-20 | 297.27M EUR derived: sum of 3 quarters · filed 2020-02-20 | 301.69M EUR derived: sum of 4 quarters · filed 2020-02-20 | |||
| 2017-12-31 | 241.31M EUR derived: 20-F 12 month − 6-K 9 month · filed 2020-02-20 | 271.49M EUR derived: sum of 2 quarters · filed 2020-02-20 | 275.92M EUR derived: sum of 3 quarters · filed 2020-02-20 | 150.61M EUR 20-F · filed 2020-02-20 | |||
| 2017-09-30 | 30.19M EUR 6-K · filed 2018-10-30 | 34.61M EUR derived: sum of 2 quarters · filed 2018-10-30 | -90.69M EUR 6-K · filed 2018-10-30 | ||||
| 2017-06-30 | 4.43M EUR 6-K · filed 2018-08-01 | -60.51M EUR 6-K · filed 2018-08-01 | |||||
| 2017-03-31 | 56.08M EUR 6-K · filed 2018-05-03 | ||||||
| 2016-12-31 | 310.58M EUR 20-F · filed 2019-02-20 | ||||||
| 2015-12-31 | 344.43M EUR 20-F · filed 2018-02-27 |